Context Capital Management, LLC - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 52 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Context Capital Management, LLC ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q4 2020$4,169,000
+1.1%
3,000,0000.0%0.57%
-36.4%
Q3 2020$4,125,0003,000,0000.90%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q1 2021
NameSharesValueWeighting ↓
TENOR CAPITAL MANAGEMENT Co., L.P. 45,447,000$60,497,0001.31%
SHENKMAN CAPITAL MANAGEMENT INC 4,366,000$5,924,0000.54%
Aequim Alternative Investments LP 7,609,000$10,088,0000.43%
MACKAY SHIELDS LLC 27,806,000$37,405,0000.35%
Weiss Asset Management LP 10,000,000$13,290,0000.33%
WOLVERINE ASSET MANAGEMENT LLC 13,230,000$17,541,0000.13%
Polar Asset Management Partners Inc. 7,500,000$9,942,0000.10%
LORD, ABBETT & CO. LLC 22,141,000$29,732,0000.07%
Calamos Advisors LLC 7,500,000$9,967,0000.05%
D. E. Shaw & Co., Inc. 39,270,000$52,046,0000.04%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders